{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:14:23Z","timestamp":1790403263827,"version":"4.1.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.berh.2012.01.012","type":"journal-article","created":{"date-parts":[[2012,3,16]],"date-time":"2012-03-16T14:49:09Z","timestamp":1331909349000},"page":"105-117","source":"Crossref","is-referenced-by-count":114,"title":["Sj\u00f6gren\u2019s syndrome, the old and the new"],"prefix":"10.1016","volume":"26","author":[{"given":"Yogev","family":"Peri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Agmon-Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel","family":"Theodor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.berh.2012.01.012_bib1","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Annals of Rheumatic Diseases"},{"issue":"12","key":"10.1016\/j.berh.2012.01.012_bib2","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/archinte.164.12.1275","article-title":"Clinical manifestations and early diagnosis of Sj\u00f6gren syndrome","volume":"164","author":"Kassan","year":"2004","journal-title":"Archives of Internal Medicine"},{"issue":"Suppl. 1","key":"10.1016\/j.berh.2012.01.012_bib3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1834-7819.2010.01197.x","article-title":"Sj\u00f6gren\u2019s syndrome: a review of aetiology, pathogenesis, diagnosis and management","volume":"55","author":"Bayetto","year":"2010","journal-title":"Australian Dental Journal"},{"issue":"3","key":"10.1016\/j.berh.2012.01.012_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/cmi.2010.70","article-title":"Explosion of autoimmune diseases and the mosaic of old and novel factors","volume":"8","author":"Agmon-Levin","year":"2011","journal-title":"Cellular and Molecular Immunology"},{"issue":"6","key":"10.1016\/j.berh.2012.01.012_bib5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2796.1996.418817000.x","article-title":"A new model for classification of disease manifestations in primary Sj\u00f6gren\u2019s syndrome: evaluation in a retrospective long-term study","volume":"239","author":"Asmussen","year":"1996","journal-title":"Journal of Internal Medicine"},{"issue":"11","key":"10.1016\/j.berh.2012.01.012_bib6","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2165\/00002512-200522110-00001","article-title":"Xerostomia secondary to Sj\u00f6gren\u2019s syndrome in the elderly: recognition and management","volume":"22","author":"Al-Hashimi","year":"2005","journal-title":"Drugs and Aging"},{"issue":"6","key":"10.1016\/j.berh.2012.01.012_bib7","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.berh.2007.09.001","article-title":"Update on Sj\u00f6gren\u2019s syndrome autoimmune epithelitis: from classification to increased neoplasias","volume":"21","author":"Tzioufas","year":"2007","journal-title":"Best Practice and Research Clinical Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2012.01.012_bib8","first-page":"55","article-title":"Sj\u00f6gren\u2019s syndrome: a retrospective review of the cutaneous features of 93 patients by the Italian Group of Immunodermatology","volume":"22","author":"Bernacchi","year":"2004","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"2","key":"10.1016\/j.berh.2012.01.012_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.md.0000119465.24818.98","article-title":"Cutaneous vasculitis in primary Sj\u00f6gren syndrome: classification and clinical significance of 52 patients","volume":"83","author":"Ramos-Casals","year":"2004","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.berh.2012.01.012_bib10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.clindermatol.2006.07.005","article-title":"Sj\u00f6gren\u2019s syndrome in dermatology","volume":"24","author":"Fox","year":"2006","journal-title":"Clinics in Dermatology"},{"issue":"1","key":"10.1016\/j.berh.2012.01.012_bib11","first-page":"88","article-title":"A study of the arthritis pattern in primary Sj\u00f6gren\u2019s syndrome","volume":"25","author":"Haga","year":"2007","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"4","key":"10.1016\/j.berh.2012.01.012_bib12","first-page":"717","article-title":"Subclinical myositis is common in primary Sj\u00f6gren\u2019s syndrome and is not related to muscle pain","volume":"29","author":"Lindvall","year":"2002","journal-title":"Journal of Rheumatology"},{"issue":"7","key":"10.1016\/j.berh.2012.01.012_bib13","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/jnnp.2010.222109","article-title":"Peripheral neuropathies in Sjogren syndrome: a new reappraisal","volume":"82","author":"Pavlakis","year":"2011","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"2","key":"10.1016\/j.berh.2012.01.012_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MD.0b013e31820fd2d1","article-title":"Peripheral neuropathies associated with primary Sj\u00f6gren syndrome: immunologic profiles of nonataxic sensory neuropathy and sensorimotor neuropathy","volume":"90","author":"S\u00e8ne","year":"2011","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.berh.2012.01.012_bib15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/NRL.0b013e3181ebe59f","article-title":"Peripheral nervous system manifestations of Sj\u00f6gren syndrome: clinical patterns, diagnostic paradigms, etiopathogenesis, and therapeutic strategies","volume":"16","author":"Birnbaum","year":"2010","journal-title":"Neurologist"},{"issue":"3","key":"10.1016\/j.berh.2012.01.012_bib16","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.revmed.2010.08.022","article-title":"Small fibre neuropathy in primary Sj\u00f6gren syndrome","volume":"32","author":"Fauchais","year":"2011","journal-title":"La Revue de m\u00e9decine interne"},{"issue":"7","key":"10.1016\/j.berh.2012.01.012_bib17","first-page":"513","article-title":"Lung involvement of primary Sj\u00f6gren\u2019s syndrome","volume":"31","author":"Yan","year":"2008","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"issue":"9","key":"10.1016\/j.berh.2012.01.012_bib18","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2215\/CJN.00980209","article-title":"Renal involvement in primary Sj\u00f6gren\u2019s syndrome: a clinicopathologic study","volume":"4","author":"Maripuri","year":"2009","journal-title":"Clinical Journal of American Society for Nephrology"},{"issue":"10","key":"10.1016\/j.berh.2012.01.012_bib19","first-page":"2495","article-title":"Renal involvement in Sj\u00f6gren\u2019s syndrome\u2013interstitial nephritis and glomerulonephritis","volume":"53","author":"Fujimoto","year":"1995","journal-title":"Nihon Rinsho"},{"key":"10.1016\/j.berh.2012.01.012_bib20","first-page":"8","article-title":"Factors predictive of renal involvement in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"56","author":"Pertovaara","year":"2001","journal-title":"Clinical Nephrology"},{"issue":"5","key":"10.1016\/j.berh.2012.01.012_bib21","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00296-003-0360-x","article-title":"Coeliac disease in Sj\u00f6gren\u2019s syndrome\u2013a study of 111 Hungarian patients","volume":"24","author":"Szodoray","year":"2004","journal-title":"Rheumatology International"},{"issue":"10","key":"10.1016\/j.berh.2012.01.012_bib22","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s10067-007-0638-6","article-title":"Thyroid disease in Sj\u00f6gren\u2019s syndrome","volume":"26","author":"Jara","year":"2007","journal-title":"Clinical Rheumatology"},{"issue":"8","key":"10.1016\/j.berh.2012.01.012_bib23","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","article-title":"Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the Inter Lymph Consortium","volume":"111","author":"Ekstr\u00f6m Smedby","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.berh.2012.01.012_bib24","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/art.10221","article-title":"Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sj\u00f6gren\u2019s syndrome","volume":"46","author":"Ioannidis","year":"2002","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2012.01.012_bib25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/art.1780360309","article-title":"Preliminary criteria for the classification of Sj\u00f6gren\u2019s syndrome. Results of a prospective concerted action supported by the European community","volume":"36","author":"Vitali","year":"1993","journal-title":"Arthritis and Rheumatism"},{"issue":"1","key":"10.1016\/j.berh.2012.01.012_bib26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jbspin.2008.02.017","article-title":"Diagnostic evaluation and classification criteria in Sj\u00f6gren\u2019s Syndrome","volume":"76","author":"G\u00e1lvez","year":"2009","journal-title":"Joint Bone Spine"},{"issue":"9","key":"10.1016\/j.berh.2012.01.012_bib27","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.autrev.2010.05.003","article-title":"The birthday of a new syndrome: IgG4-related diseases constitute a clinical entity","volume":"9","author":"Takahashi","year":"2010","journal-title":"Autoimmunity Reviews"},{"issue":"8","key":"10.1016\/j.berh.2012.01.012_bib28","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1136\/ard.2008.089169","article-title":"Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders","volume":"68","author":"Masaki","year":"2009","journal-title":"Annals of Rheumatic Diseases"},{"key":"10.1016\/j.berh.2012.01.012_bib29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000315025","article-title":"Diagnostic markers of Sj\u00f6gren\u2019s syndrome","volume":"45","author":"Witte","year":"2010","journal-title":"Developments in Ophthalmology"},{"issue":"6","key":"10.1016\/j.berh.2012.01.012_bib30","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.semarthrit.2010.07.006","article-title":"Relation of systemic autoantibodies to the number of extraglandular manifestations in primary Sj\u00f6gren\u2019s Syndrome: a retrospective analysis of 65 patients in the Netherlands","volume":"40","author":"Ter Borg","year":"2011","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"3","key":"10.1016\/j.berh.2012.01.012_bib31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.autrev.2010.09.001","article-title":"The meaning of anti-Ro and anti-La antibodies in primary Sj\u00f6gren\u2019s syndrome","volume":"10","author":"Hern\u00e1ndez-Molina","year":"2011","journal-title":"Autoimmunity Reviews"},{"issue":"16","key":"10.1016\/j.berh.2012.01.012_bib32","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.berh.2012.01.012_bib33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/art.1780270205","article-title":"Labial salivary gland biopsy in Sj\u00f6gren\u2019s syndrome. Assessment as a diagnostic criterion in 362 suspected cases","volume":"27","author":"Daniels","year":"1984","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"10.1016\/j.berh.2012.01.012_bib34","doi-asserted-by":"crossref","first-page":"A305","DOI":"10.1016\/j.autrev.2009.11.004","article-title":"The geoepidemiology of Sj\u00f6gren\u2019s syndrome","volume":"9","author":"Mavragani","year":"2010","journal-title":"Autoimmunity Reviews"},{"issue":"8","key":"10.1016\/j.berh.2012.01.012_bib35","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nrrheum.2010.86","article-title":"Geoepidemiology of autoimmune rheumatic diseases","volume":"6","author":"Shapira","year":"2010","journal-title":"Nature Reviews Rheumatology"},{"issue":"22","key":"10.1016\/j.berh.2012.01.012_bib36","first-page":"3252","article-title":"Clinical and prognostic characteristics of 573 cases of primary Sj\u00f6gren\u2019s syndrome","volume":"123","author":"Lin","year":"2010","journal-title":"Chinese Medical Journal (English)"},{"issue":"9","key":"10.1016\/j.berh.2012.01.012_bib37","first-page":"2264","article-title":"Monozygotic twins with primary Sjogren\u2019s syndrome","volume":"27","author":"Bolstad","year":"2000","journal-title":"Journal of Rheumatology"},{"issue":"4","key":"10.1016\/j.berh.2012.01.012_bib38","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1086\/429096","article-title":"Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620 W allele associates with multiple autoimmune phenotypes","volume":"76","author":"Criswell","year":"2005","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.berh.2012.01.012_bib39","unstructured":"Cruz-Tapias P, Rojas-Villarraga A, Maier-Moore S, Anaya JM. HLA and Sj\u00f6gren\u2019s syndrome susceptibility. A meta-analysis of worldwide studies. Autoimmunity Reviews, in press."},{"issue":"4","key":"10.1016\/j.berh.2012.01.012_bib40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0198-8859(93)90130-S","article-title":"Molecular analysis of HLA class II genes in primary Sj\u00f6gren\u2019s syndrome. A study of Israeli Jewish and Greek non-Jewish patients","volume":"36","author":"Roitberg-Tambur","year":"1993","journal-title":"Human Immunology"},{"key":"10.1016\/j.berh.2012.01.012_bib41","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/gene.2008.94","article-title":"Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sj\u00f6gren\u2019s syndrome","volume":"10","author":"Nordmark","year":"2009","journal-title":"Genes and Immunity"},{"key":"10.1016\/j.berh.2012.01.012_bib42","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1002\/art.24662","article-title":"The CGGGG insertion\/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sj\u00f6gren\u2019s syndrome","volume":"60","author":"Miceli-Richard","year":"2009","journal-title":"Arthritis and Rheumatism"},{"issue":"3","key":"10.1016\/j.berh.2012.01.012_bib43","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/gene.2008.1","article-title":"Variant form of STAT4 is associated with primary Sjogren\u2019s syndrome","volume":"9","author":"Korman","year":"2008","journal-title":"Genes and Immunity"},{"issue":"10","key":"10.1016\/j.berh.2012.01.012_bib44","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa073003","article-title":"STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus","volume":"357","author":"Remmers","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.berh.2012.01.012_bib45","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3899\/jrheum.100486","article-title":"Activation of the interferon pathway in peripheral blood of patients with Sjogren\u2019s syndrome","volume":"38","author":"Kimoto","year":"2011","journal-title":"Journal of Rheumatology"},{"issue":"6","key":"10.1016\/j.berh.2012.01.012_bib46","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/rheumatology\/40.6.656","article-title":"Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjogren\u2019s syndrome and correlate with the clinical manifestations of the disease","volume":"40","author":"Hulkkonen","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2012.01.012_bib47","doi-asserted-by":"crossref","first-page":"12628","DOI":"10.1073\/pnas.0405099101","article-title":"Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sj\u00f6gren\u2019s syndrome","volume":"101","author":"Shim","year":"2004","journal-title":"Proceeding of the National Academy of Sciences of USA"},{"issue":"7","key":"10.1016\/j.berh.2012.01.012_bib48","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1582-4934.2009.00727.x","article-title":"Healthy human salivary glands contain a DHEA-S processing intracrine machinery, which is deranged in primary Sjogren\u2019s syndrome","volume":"13","author":"Spaan","year":"2009","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.berh.2012.01.012_bib49","first-page":"1259","article-title":"Low serum dehydroepiandrosterone sulfate in women with primary Sjogren\u2019s syndrome as an isolated sign of impaired HPA axis function","volume":"28","author":"Valtysdottir","year":"2001","journal-title":"Journal of Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2012.01.012_bib50","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s12016-009-8185-3","article-title":"Prolactin and autoimmunity","volume":"40","author":"Jara","year":"2011","journal-title":"Clinical Reviews in Allergy Immunology"},{"key":"10.1016\/j.berh.2012.01.012_bib51","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1297-319X(03)00151-9","article-title":"Hyperprolactinemia in Sjogren\u2019s syndrome: a patient subset or a disease manifestation?","volume":"71","author":"El Miedany","year":"2004","journal-title":"Joint Bone Spine"},{"issue":"3","key":"10.1016\/j.berh.2012.01.012_bib52","first-page":"174","article-title":"The role of vitamin D in regulating immune responses","volume":"12","author":"Toubi","year":"2010","journal-title":"Israel Medical Association Journal"},{"issue":"2","key":"10.1016\/j.berh.2012.01.012_bib53","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/rheumatology\/kep374","article-title":"The immunoregulatory role of vitamins A, D and E in patients with primary Sjogren\u2019s syndrome","volume":"49","author":"Szodoray","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.berh.2012.01.012_bib54","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.it.2009.05.005","article-title":"Infections and autoimmunity\u2013friends or foes?","volume":"30","author":"Kivity","year":"2009","journal-title":"Trends in Immunology"},{"issue":"11","key":"10.1016\/j.berh.2012.01.012_bib55","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1136\/ard.2010.128736","article-title":"Association of human T lymphotropic virus type I with Sjogren syndrome","volume":"69","author":"Hida","year":"2010","journal-title":"Annals of Rheumatic Diseases"},{"issue":"5","key":"10.1016\/j.berh.2012.01.012_bib56","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.berh.2008.09.007","article-title":"Epstein-Barr virus in autoimmune diseases","volume":"22","author":"Toussirot","year":"2008","journal-title":"Best Practice and Research Clinical Rheumatology"},{"issue":"8789","key":"10.1016\/j.berh.2012.01.012_bib57","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0140-6736(92)91645-O","article-title":"Lymphocytic sialadenitis of Sj\u00f6gren\u2019s syndrome associated with chronic hepatitis C virus liver disease","volume":"339","author":"Haddad","year":"1992","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.berh.2012.01.012_bib58","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jaut.2010.06.012","article-title":"Activation of the type I interferon pathway in primary Sjogren\u2019s syndrome","volume":"35","author":"Mavragani","year":"2010","journal-title":"Journal of Autoimmunity"},{"issue":"5","key":"10.1016\/j.berh.2012.01.012_bib59","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/BOR.0b013e328349fd30","article-title":"Activation of the type I interferon pathway in primary Sj\u00f6gren\u2019s syndrome: an update","volume":"23","author":"Vakaloglou","year":"2011","journal-title":"Current Opinion in Rheumatology"},{"key":"10.1016\/j.berh.2012.01.012_bib60","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1073\/pnas.0510837103","article-title":"Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren\u2019s syndrome","volume":"103","author":"Gottenberg","year":"2006","journal-title":"Proceeding of the National Academy of Sciences of USA"},{"issue":"9","key":"10.1016\/j.berh.2012.01.012_bib61","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.autrev.2010.05.006","article-title":"B-cell tolerance breakdown in Sj\u00f6gren\u2019s syndrome: focus on BAFF","volume":"9","author":"Varin","year":"2010","journal-title":"Autoimmunity Reviews"},{"issue":"12","key":"10.1016\/j.berh.2012.01.012_bib62","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1002\/art.24980","article-title":"Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sj\u00f6gren\u2019s syndrome","volume":"60","author":"Vosters","year":"2009","journal-title":"Arthritis and Rheumatism"},{"issue":"1","key":"10.1016\/j.berh.2012.01.012_bib63","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/08959374960100010601","article-title":"Sj\u00f6gren\u2019s syndrome: immunobiology of exocrine gland dysfunction","volume":"10","author":"Fox","year":"1996","journal-title":"Advances in Dental Research"},{"issue":"1","key":"10.1016\/j.berh.2012.01.012_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2011.06.007","article-title":"The complexity of Sj\u00f6gren\u2019s syndrome: novel aspects on pathogenesis","volume":"141","author":"Jonsson","year":"2011","journal-title":"Immunology Letters"},{"key":"10.1016\/j.berh.2012.01.012_bib65","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/art.21764","article-title":"Antimuscarinic antibodies in primary Sj\u00f6gren\u2019s syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells","volume":"54","author":"Dawson","year":"2006","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2012.01.012_bib66","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/labinvest.3780221","article-title":"Abnormal distribution of aquaporin-5 water channel protein in salivary glands from Sj\u00f6gren\u2019s syndrome patients","volume":"81","author":"Steinfeld","year":"2001","journal-title":"Laboratory Investigation"},{"key":"10.1016\/j.berh.2012.01.012_bib67","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1002\/art.10440","article-title":"Treatment with infliximab restores normal aquaporin 5 distribution in minor salivary glands of patients with Sj\u00f6gren\u2019s syndrome","volume":"46","author":"Steinfeld","year":"2002","journal-title":"Arthritis and Rheumatism"},{"issue":"7","key":"10.1016\/j.berh.2012.01.012_bib68","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1136\/ard.2007.074203","article-title":"Exocrine function in primary Sj\u00f6gren syndrome: natural course and prognostic factors","volume":"67","author":"Haldorsen","year":"2008","journal-title":"Annals of Rheumatic Diseases"},{"issue":"3","key":"10.1016\/j.berh.2012.01.012_bib69","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1157\/13115353","article-title":"Prognosis of patients with primary Sj\u00f6gren\u2019s syndrome","volume":"130","author":"Brito-Zer\u00f3n","year":"2008","journal-title":"Medicina Clinica (Barc)"},{"issue":"8","key":"10.1016\/j.berh.2012.01.012_bib70","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/rheumatology\/kem079","article-title":"Predicting adverse outcomes in primary Sjogren\u2019s syndrome: identification of prognostic factors","volume":"46","author":"Brito-Zer\u00f3n","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.berh.2012.01.012_bib71","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/ard.2009.110619","article-title":"EULAR Sjogren\u2019s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren\u2019s syndrome","volume":"69","author":"Seror","year":"2010","journal-title":"Annals of Rheumatic Diseases"},{"issue":"6","key":"10.1016\/j.berh.2012.01.012_bib72","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/ard.2010.143743","article-title":"EULAR Sjogren\u2019s Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren\u2019s syndrome","volume":"70","author":"Seror","year":"2011","journal-title":"Annals of Rheumatic Diseases"},{"key":"10.1016\/j.berh.2012.01.012_bib73","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archinte.159.2.174","article-title":"Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sj\u00f6gren syndrome","volume":"159","author":"Vivino","year":"1999","journal-title":"Archives of Internal Medicine"},{"issue":"4","key":"10.1016\/j.berh.2012.01.012_bib74","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease","volume":"107","author":"Sall","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.berh.2012.01.012_bib75","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/art.27766","article-title":"Efficacy and safety of an intraoral electrostimulation device for xerostomia relief: A multicenter, randomized trial","volume":"63","author":"Strietzel","year":"2011","journal-title":"Arthritis and Rheumatism"},{"issue":"2","key":"10.1016\/j.berh.2012.01.012_bib76","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.joms.2010.10.002","article-title":"Endoscopic treatment of salivary glands affected by autoimmune diseases","volume":"69","author":"Shacham","year":"2011","journal-title":"Journal of Oral and Maxillofacial Surgery"},{"issue":"4","key":"10.1016\/j.berh.2012.01.012_bib77","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1001\/jama.2010.1014","article-title":"Treatment of primary sjogren syndrome, a systematic review","volume":"304","author":"Ramos-Casals","year":"2010","journal-title":"Journal of Aerican Medical Association"},{"key":"10.1016\/j.berh.2012.01.012_bib78","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/ard.52.5.360","article-title":"Hydroxychloroquine treatment for primary Sj\u00f6gren\u2019s syndrome: a two year double blind crossover trial","volume":"52","author":"Kruize","year":"1993","journal-title":"Annals of Rheumatic Diseases"},{"issue":"11","key":"10.1016\/j.berh.2012.01.012_bib79","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1093\/brain\/awh605","article-title":"The wide spectrum of clinical manifestations in sjogren\u2019s syndrome-associated neuropathy","volume":"128","author":"Keikp","year":"2005","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.berh.2012.01.012_bib80","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/01.md.0000141099.53742.16","article-title":"Neurologic manifestations in primary Sj\u00f6gren syndrome: a study of 82 patients","volume":"83","author":"Delalande","year":"2004","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1016\/j.berh.2012.01.012_bib81","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1136\/ard.2002.003996","article-title":"Intravenous immunoglobulins in peripheral neuropathy associated with vasculitis","volume":"62","author":"Levy","year":"2003","journal-title":"Annals of Rheumatic Diseases"},{"issue":"Suppl. 2","key":"10.1016\/j.berh.2012.01.012_bib82","doi-asserted-by":"crossref","first-page":"S204","DOI":"10.1016\/j.jaci.2009.10.067","article-title":"Immunologic rheumatic disorders","volume":"125","author":"Joseph","year":"2010","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"6","key":"10.1016\/j.berh.2012.01.012_bib83","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MD.0b013e318190f170","article-title":"A systematic review of the off-label use of biological therapies in systemic autoimmune diseases","volume":"87","author":"Ramos Casals","year":"2008","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.berh.2012.01.012_bib84","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.autrev.2009.08.001","article-title":"B cell targeted therapies in sjogren syndrome","volume":"9","author":"Tob\u00f3n","year":"2010","journal-title":"Autoimmunity Reviews"},{"issue":"9","key":"10.1016\/j.berh.2012.01.012_bib85","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.autrev.2010.05.007","article-title":"The point on the ongoing B cell depleting trials","volume":"9","author":"Saraux","year":"2010","journal-title":"Autoimmunity Reviews"},{"issue":"4","key":"10.1016\/j.berh.2012.01.012_bib86","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/art.27314","article-title":"Effectiveness of rituximab treatment in primary sjogren\u2019s syndrome","volume":"62","author":"Meijer","year":"2010","journal-title":"Arthritis and Rheumatism"},{"issue":"2","key":"10.1016\/j.berh.2012.01.012_bib87","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/ard.2008.092601","article-title":"Treatment of primary sjogren\u2019s syndrome with rituximab:extended follow up. Safety and efficacy of retreatment","volume":"68","author":"Meijer","year":"2009","journal-title":"Annals of Rheumatic Diseases"},{"issue":"1","key":"10.1016\/j.berh.2012.01.012_bib88","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/annrheumdis-2011-200086","article-title":"Efficacy of rituximab in primary Sjogren\u2019s syndrome with peripheral nervous system involvement: results from the AIR registry","volume":"71","author":"Mekinian","year":"2012","journal-title":"Annals of Rheumatic Diseases"},{"issue":"11","key":"10.1016\/j.berh.2012.01.012_bib89","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1002\/art.24903","article-title":"Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sj\u00f6gren\u2019s syndrome","volume":"60","author":"Pijpe","year":"2009","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"10.1016\/j.berh.2012.01.012_bib90","first-page":"953","article-title":"Targeting CD22 as a strategy for treating systemic autoimmune diseases","volume":"3","author":"D\u00f6rner","year":"2007","journal-title":"Therapeutic and Clinical Risk Management"},{"issue":"7","key":"10.1016\/j.berh.2012.01.012_bib91","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.4049\/jimmunol.1003412","article-title":"Targeting B cells for the treatment of SLE: the beginning of the end or the end of the beginning?","volume":"186","author":"Horton","year":"2011","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.berh.2012.01.012_bib92","series-title":"Diagnostic criteria in autoimmune diseases","first-page":"37","article-title":"Sjogren syndrome","author":"Mitsias","year":"2008"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694212000137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694212000137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,25]],"date-time":"2018-11-25T08:55:54Z","timestamp":1543136154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694212000137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1521694212000137"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2012.01.012","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}